Task: Answer the multiple choice question.
Question: Which drug exhibits a 12.564% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCOc1ncccc1C(=O)OCC(=O)Nc1ccc2c(c1)OCO2
(b) O=C(CCNS(=O)(=O)c1ccc(Cl)cc1)Nc1ccncc1
Answer: a. CCOc1ncccc1C(=O)OCC(=O)Nc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ncccc1C(=O)OCC(=O)Nc1ccc2c(c1)OCO2
CCOc1ncccc1C(=O)OCC(=O)Nc1ccc2c(c1)OCO2
[2-(1,3-benzodioxol-5-ylamino)-2-oxoethyl] 2-ethoxypyridine-3-carboxylate